Adrenaline 150 microgram auto-injector validation process no longer required

Adrenaline 150 microgram auto-injector validation process no longer required

November 28, 2018

From Thursday 29th November, adrenaline 150microgram auto-injectors will no longer be subject to additional validation processes.

The Department of Health and Social Care (DHSC) has stated that stock levels are now at a level where the validation protocol put in place in October, and revised earlier this month, is no longer required.*

Community pharmacy teams will, therefore, be permitted to dispense the total number of adrenaline 150microgram auto-injectors prescribed to each patient. However, whilst stock filters through the supply chain, some wholesalers may still apply a restriction to ordering levels. Pharmacy teams may wish to discuss this with their usual wholesaler.

PSNC will continue to monitor the supply of adrenaline auto-injectors and will support DHSC and NHS England in their efforts to ensure the return to normal dispensing runs smoothly.

*Please note, EpiPen products were subject to prescription validation prior to the protocol introduced October and this will continue as before, pharmacies will be able to order up to a maximum of two EpiPen Junior devices per prescription.



Posted in: ,


More Latest News >

EPS Phase 4 piloting

NHS Digital continues to pilot EPS Phase 4. All pharmacy staff need to be aware that they could receive a...

PSNC Job Opportunity: Office Administrator

PSNC (the Pharmaceutical Services Negotiating Committee) represents England’s community (high-street) pharmacies, and is looking to recruit an Office Administrator to...